Lilly takes full ownership of biotech company Protomer Technologies
Eli Lilly and Company (Lilly) has taken full ownership of California-based biotech company Protomer Technologies in a deal that is potentially worth more than $1 ... Read More
Pepticom secures investment for AI-driven peptide drug discovery
Israel-based Pepticom, which is engaged in using artificial intelligence (AI) for peptide drug discovery, has raised $5 million in a Series A funding round from the ... Read More